Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2111 (LINC02111)

Target
LINC02111
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2111 (LINC02111) is a human non-coding RNA gene that produces a long intergenic non-coding RNA transcript. LINC02111 does not encode a protein and is classified as a lincRNA, meaning it is longer than 200 nucleotides and its gene locus does not overlap protein-coding genes[1][5][3]. While the general class of lincRNAs is known to be involved in diverse regulatory processes such as chromatin remodeling, gene expression regulation, genome architecture, and sometimes acting with enhancer-like functions, the specific biological functions, disease associations, or therapeutic targeting potential of LINC02111 itself have not yet been defined in the scientific literature[1][5][3][7]. No drugs, diagnostic biomarkers, or safety concerns are currently associated with this molecule. Note: LINC02111 is a canonical example of a human lincRNA gene with insufficient direct functional or therapeutic targeting data as of current knowledge. Most available information about its class is extrapolated from general principles of lincRNAs, not from specific characterization of LINC02111.

Other names
CTD-2139B15.4LINC02111
02

Biological functions

Regulation of gene expressionChromatin remodelingGenome architecture modulationRNA stabilizationTranscriptional regulation (potential enhancer-like activity)
03

Disease associations

Other (No direct disease association reported; lincRNAs in general may be involved in cancer or other diseases, but no evidence specifically for LINC02111)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2111 (LINC02111).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2111 (LINC02111).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call